CoChat

Incidence and outcomes of acute mesenteric ischaemia: a systematic review and meta-analysis

Open access
Tamme, Kadri, Reintam Blaser, Annika, Laisaar, Kaja-Triin, Mändul, Merli, Kals, Jaak, Forbes, Alastair, Kiss, Olga, Acosta, Stefan, Bjørck, Martin, Starkopf, Joel · 2022 · BMJ Open

The DOI matches its Crossref record; 185 of the 209 references it cites were found in a registry or an index; 9 of the 60 sources its claims cite were checked for support.

Abstract

Objective: To estimate the incidence of acute mesenteric ischaemia (AMI), proportions of its different forms and short-term and long-term mortality. Design: Systematic review and meta-analysis. Data sources: MEDLINE (Ovid), Web of Science, Scopus and Cochrane Library were searched until 26 July 2022. Eligibility criteria: Studies reporting data on the incidence and outcomes of AMI in adult populations. Data extraction and synthesis: Data extraction and quality assessment with modified Newcastle-Ottawa scale were performed using predeveloped standard forms. The outcomes were the incidence of AMI and its different forms in the general population and in patients admitted to hospital, and the mortality of AMI in its different forms. Results: From 3064 records, 335 full texts were reviewed and 163 included in the quantitative analysis. The mean incidence of AMI was 6.2 (95% CI 1.9 to 12.9) per 100 000 person years. On average 5.0 (95% CI 3.3 to 7.1) of 10 000 hospital admissions were due to AMI. Occlusive arterial AMI was the most common form constituting 68.6% (95% CI 63.7 to 73.2) of all AMI cases, with similar proportions of embolism and thrombosis. Overall short-term mortality (in-hospital or within 30 days) of AMI was 59.6% (95% CI 55.5 to 63.6), being 68.7% (95% CI 60.8 to 74.9) in patients treated before the year 2000 and 55.0% (95% CI 45.5 to 64.1) in patients treated from 2000 onwards (p<0.05). The mid/long-term mortality of AMI was 68.2% (95% CI 60.7 to 74.9). Mortality due to mesenteric venous thrombosis was 24.6% (95% CI 17.0 to 32.9) and of non-occlusive mesenteric ischaemia 58.4% (95% CI 48.6 to 67.7). The short-term mortality of revascularised occlusive arterial AMI was 33.9% (95% CI 30.7 to 37.4). Conclusions: In adult patients, AMI is a rarely diagnosed condition with high mortality, although with improvement of treatment results over the last decades. Two thirds of AMI cases are of occlusive arterial origin with potential for better survival if revascularised. PROSPERO registration number: CRD42021247148.

Overview

CoChat Summary

TL;DR

This systematic review and meta-analysis estimates that acute mesenteric ischaemia (AMI) is rare but highly lethal, with an incidence of 6.2 per 100 000 person years and short-term mortality of 59.6%. Occlusive arterial AMI is the most common form, and revascularised occlusive arterial AMI has substantially lower short-term mortality.

Key findings

  • Mean AMI incidence was 6.2 (95% CI 1.9 to 12.9) per 100 000 person years, and 5.0 (95% CI 3.3 to 7.1) of 10 000 hospital admissions were due to AMI.
  • Occlusive arterial AMI constituted 68.6% (95% CI 63.7 to 73.2) of cases; NOMI accounted for 15.1% (95% CI 11.8 to 18.7) and MVT for 11.5% (95% CI 9.1 to 14.2).
  • Overall short-term mortality was 59.6% (95% CI 55.5 to 63.6), improving from 68.7% (95% CI 60.8 to 74.9) before 2000 to 55.0% (95% CI 45.5 to 64.1) from 2000 onwards (p<0.05).
  • Short-term mortality was 33.9% (95% CI 30.7 to 37.4) in revascularised occlusive arterial AMI, 58.4% (95% CI 48.6 to 67.7) in NOMI, and 24.6% (95% CI 17.0 to 32.9) in MVT; mid/long-term mortality for all AMI was 68.2% (95% CI 60.7 to 74.9).

Methods

  • Systematic review and meta-analysis of studies reporting incidence and outcomes of AMI in adult populations, searched in MEDLINE (Ovid), Web of Science, Scopus and Cochrane Library until 26 July 2022.
  • From 3064 records, 335 full texts were reviewed and 163 studies were included in quantitative analysis (152 retrospective, 11 prospective); quality was assessed with a modified Newcastle-Ottawa Scale.
  • Random-effects meta-analyses pooled incidence per 100 000 person years and proportions for mortality and AMI subtypes; random-effects meta-regression compared estimates.

Limitations

  • The authors state that excluding “colonic ischaemia” and “ischaemic colitis” from the search may have missed some AMI studies; most included studies were retrospective, single-centre, and covered long time periods; pooling involved somewhat different definitions and management algorithms; and publication and assessment biases were possible.
  • The paper also notes that meta-analyses on mortality by age group or gender, and assessment of other outcomes, were not possible, and that four Chinese-language articles were excluded because no team member had command of Chinese.
  • The text makes evident that incidence is likely underestimated because many AMI cases are diagnosed only at autopsy and autopsy rates are generally low; the included incidence studies were exclusively from high-income countries and covered 1970–2013.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2022-062846

Cites

185 of 185 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Flow diagram showing the selection of studies included in the review. AMI, acute mesenteric ischaemia; MVT, mesenteric vein thrombosis; OcclArtAMI, occlusive arterial AMI.
Figure 1 Flow diagram showing the selection of studies included in the review. AMI, acute mesenteric ischaemia; MVT, mesenteric vein thrombosis; OcclArtAMI, occlusive arterial AMI.CC BY-NC · PubMed Central
Figure 2 Incidence of acute mesenteric ischaemia in general population, cases per 100 000 person years.
Figure 2 Incidence of acute mesenteric ischaemia in general population, cases per 100 000 person years.CC BY-NC · PubMed Central
Figure 3 Proportion of patients with acute mesenteric ischaemia (AMI) among hospitalised patients.
Figure 3 Proportion of patients with acute mesenteric ischaemia (AMI) among hospitalised patients.CC BY-NC · PubMed Central
Figure 4 Short-term (hospital or 30 days) mortality of acute mesenteric ischaemia (all forms). Subgroup analyses of studies including all patients independent of treatment method (upper panel) and of studies including only operated patients (lower panel) are presented. In brackets, the period of patient inclusion is indicated. AMI, acute mesenteric ischaemia.
Figure 4 Short-term (hospital or 30 days) mortality of acute mesenteric ischaemia (all forms). Subgroup analyses of studies including all patients independent of treatment method (upper panel) and of studies including only operated patients (lower panel) are presented. In brackets, the period of patient inclusion is indicated. AMI, acute mesenteric ischaemia.CC BY-NC · PubMed Central
Figure 5 Long-term (6 months to 5 years) mortality of acute mesenteric ischaemia, all forms. Subgroup analyses of studies including patients independent of treatment method (upper panel) and of studies including only operated patients (lower panel) are presented. In brackets, the period of patient inclusion is indicated. AMI, acute mesenteric ischaemia.
Figure 5 Long-term (6 months to 5 years) mortality of acute mesenteric ischaemia, all forms. Subgroup analyses of studies including patients independent of treatment method (upper panel) and of studies including only operated patients (lower panel) are presented. In brackets, the period of patient inclusion is indicated. AMI, acute mesenteric ischaemia.CC BY-NC · PubMed Central
Figure 6 Long-term (6 months to 5 years) mortality of occlusive arterial acute mesenteric ischaemia (OcclArtAMI). Subgroup analyses of studies including patients independent of treatment method (upper panel), of studies including only operated patients (middle panel), and of studies including only patients with revascularisation (lower panel) are presented. In brackets, the period of patient inclusion is indicated.
Figure 6 Long-term (6 months to 5 years) mortality of occlusive arterial acute mesenteric ischaemia (OcclArtAMI). Subgroup analyses of studies including patients independent of treatment method (upper panel), of studies including only operated patients (middle panel), and of studies including only patients with revascularisation (lower panel) are presented. In brackets, the period of patient inclusion is indicated.CC BY-NC · PubMed Central
Figure 7 Long-term (2 months to 5 years) mortality of mesenteric vein thrombosis (MVT). In brackets, the period of patient inclusion is indicated.
Figure 7 Long-term (2 months to 5 years) mortality of mesenteric vein thrombosis (MVT). In brackets, the period of patient inclusion is indicated.CC BY-NC · PubMed Central

Verification

Claims the paper makes

4 Valid · 3 Not valid · 32 Not checked · 32 Own results and interpretations

42 more claims

Create a free account to see all 71 claims and to verify the 4 references still open.

See all claims — free account
  • Probably not a substantial claim. 5
  • It may state two separate claims as one. 21

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

14 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

3 of 3

Citations

Cites

Show all 185 references

Research works printed but not linked: 1

  1. Lotti, 2003, La procedura "second-look” nella terapia chirurgica dell’infarto intestinale [“Second-look” in the surgical therapy of mesenteric infarction], Chirurgia, 16, 163

Cited by

See all 112

Metadata

Authors
Tamme, K., Reintam Blaser, A., Laisaar, K.-T., Mändul, M., Kals, J., Forbes, A., Kiss, O., Acosta, S., Bjørck, M., & Starkopf, J.
Affiliations
  • Tartu University Hospital (EE)
  • Department of Anaesthesiology and Intensive Care, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia
  • University of Tartu (EE)
  • Lund University (SE)
  • Department of Surgery, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia
Corresponding author
Tamme, Kadri
Venue
BMJ Open
Publisher
BMJ
Published
2022-10
Volume
12
Issue
10
Pages
e062846
ISSN
2044-6055 (ISSN-L)
OpenAlex
W4307690455
Cited by
112
References
209
Citations by year
2026: 33 · 2025: 33 · 2024: 28 · 2023: 17 · 2022: 1
FWCI
4.75
Type
journal article
Language
en
Open access
Locations
  • BMJ Open (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
Eesti Teadusagentuur (PRG1255)
Topics
  • Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Aortic Thrombus and Embolism
  • Health Sciences › Medicine › Emergency Medicine › Appendicitis Diagnosis and Management
Keywords
acute mesenteric ischemia, incidence, mortality, mesenteric vein thrombosis, nonocclusive mesenteric ischemia, embolism, thrombosis, hospitalization, treatment trends, long-term outcomes, adults, case definition, diagnostic criteria, risk factors, prognosis, prognostic score, risk stratification
MeSH terms
Acute Disease, Adult, Humans, Ischemia, Thrombosis, Incidence, Treatment Outcome, Mesenteric Ischemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Incidence and outcomes of acute mesenteric ischaemia: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1136/bmjopen-2022-062846
The paper
Tamme, K., Reintam Blaser, A., Laisaar, K.-T., Mändul, M., Kals, J., Forbes, A., Kiss, O., Acosta, S., Bjørck, M., & Starkopf, J. (2022). Incidence and outcomes of acute mesenteric ischaemia: a systematic review and meta-analysis. BMJ Open. https://doi.org/10.1136/bmjopen-2022-062846

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.